The estimated Net Worth of Daniel J Bevevino is at least 1 百万$ dollars as of 5 May 2011. Mr. Bevevino owns over 10,000 units of Artivion Inc stock worth over 804,600$ and over the last 21 years he sold CRY stock worth over 0$. In addition, he makes 195,015$ as Independent Director at Artivion Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Bevevino CRY stock SEC Form 4 insiders trading
Daniel has made over 3 trades of the Artivion Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of CRY stock worth 50,000$ on 5 May 2011.
The largest trade he's ever made was exercising 31,499 units of Artivion Inc stock on 28 January 2004 worth over 873,782$. On average, Daniel trades about 2,798 units every 102 days since 2004. As of 5 May 2011 he still owns at least 45,000 units of Artivion Inc stock.
You can see the complete history of Mr. Bevevino stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Daniel Bevevino biography
Daniel J. Bevevino is an Independent Director of CryoLife, Inc., Mr. Bevevino has served as a director of CryoLife since December 2003. From 1996 until March 2008, Mr. Bevevino served as the Vice President and Chief Financial Officer of Respironics, Inc., a company that developed, manufactured and marketed medical devices used primarily for the treatment of patients suffering from sleep and respiratory disorders. He was employed by Respironics beginning in 1988. In March 2008, Respironics was acquired by Royal Philips Electronics (NYSE: PHG) (“Philips”), whose businesses included a variety of medical solutions including medical diagnostic imaging and patient monitoring systems, as well as businesses focused on energy efficient lighting and consumer products. From March 2008 to December 31, 2009, Mr. Bevevino was employed by Philips as the Head of Post-Merger Integration – Respironics, as well as in various operating capacities, to help facilitate the integration of the combined companies. He is currently an independent consultant providing interim chief financial officer services in the life sciences industry, and he currently serves as a director of one of the private companies for which he provides services. He began his career as a Certified Public Accountant with Ernst & Young LLP. Mr. Bevevino’s license is currently inactive. Mr. Bevevino received a B.S. in Business Administration from Duquesne University and an MBA from the University of Notre Dame.
What is the salary of Daniel Bevevino?
As the Independent Director of Artivion Inc, the total compensation of Daniel Bevevino at Artivion Inc is 195,015$. There are 10 executives at Artivion Inc getting paid more, with James Mackin having the highest compensation of 6,453,540$.
How old is Daniel Bevevino?
Daniel Bevevino is 60, he's been the Independent Director of Artivion Inc since 2003. There are 7 older and 16 younger executives at Artivion Inc. The oldest executive at Artivion Inc is Ronald McCall, 83, who is the Presiding Independent Director.
Insiders trading at Artivion Inc
Over the last 21 years, insiders at Artivion Inc have traded over 18,346,910$ worth of Artivion Inc stock and bought 91,700 units worth 1,086,548$ . The most active insiders traders include Steven G Anderson、Thomas F Ackerman、James P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of 211,842$. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth 46,425$.
What does Artivion Inc do?
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
What does Artivion Inc's logo look like?
Complete history of Mr. Bevevino stock trades at Artivion Inc、WisdomTree Trust
Artivion Inc executives and stock owners
Artivion Inc executives and other stock owners filed with the SEC include:
-
James Mackin,
Chairman of the Board, President, Chief Executive Officer, Director -
D. Ashley Lee,
Chief Financial Officer, Chief Operating Officer, Executive Vice President -
Jean Holloway,
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary -
Michael Simpson,
Senior Vice President - Regulatory Affairs and Quality Assurance -
John Davis,
Senior Vice President - Global Sales and Marketing -
James Patrick Mackin,
Chairman, Pres & CEO -
Scott Capps,
Vice President - Clinical Research -
David Ashley Lee CPA, CPA,
Exec. VP, COO & CFO -
Jean F. Holloway Esq.,
Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. -
John E. Davis,
Sr. VP of Global Sales & Marketing -
Harvey Morgan,
Independent Director -
Daniel Bevevino,
Independent Director -
Ronald McCall,
Presiding Independent Director -
Thomas Ackerman,
Independent Director -
Jon Salveson,
Independent Director -
James Bullock,
Independent Director -
Jeffrey Burbank,
Independent Director -
Marna Borgstrom,
Independent Director -
Greg Chodaczek,
IR Contact Officer -
Matthew Getz,
Vice President - Human Resources -
Dennis Maier,
Vice President - Operations -
Amy Horton,
Chief Accounting Officer, Vice President -
Thomas Bogenschutz,
Senior Vice President - EMEA, General Manager - Hechingen -
Dr. Marshall S. Stanton,
Sr. VP of Clinical Research & Chief Medical Officer -
Joshua Wells,
Sr. Director of Bus. Devel. -
Matthew A. Getz,
VP of HR -
Amy D. Horton CPA, CPA,
VP & Chief Accounting Officer -
Sherry M Saurini,
VP, Quality -
C Elkins Ronald,
Director -
James Benson,
Director -
James M Mc Dermid,
SVP, CHRO -
David C Gale,
VP-Research and Development -
William Robert Matthews,
Senior VP, Operations, Quality -
Thomas J Bogenschuetz,
VP, EMEA & General Manager -
Bruce G. Anderson,
VP, US Sales and Marketing -
Jeffrey W Burris,
Vice President & Gen. Counsel -
Gerald B Seery,
Sr. VP, Sales and Marketing -
John M Cook,
Director -
David P. Lang,
Sr. VP, Intl Sales & Marketing -
Steven G Anderson,
President, CEO and Chairman -
Thomas J Lynch,
VP - Reg. Aff./Quality Assur. -
Capital Management Oss,
10% owner -
Philip A Theodore,
VP, General Counsel -
Michaelstark Brian Jay Roth,
-
Sidney B Ashmore,
Vice President of Marketing -
Virginia C Lacy,
Director -
Dyne Bruce J Md Van,
Director -
Albert E Heacox,
Sr. VP-Laboratory Operations -
Vander James C Wyk,
VP - Product Integrity -
Kirby S Black,
Sr. Vice President, R&D -
David Fronk,
VP - Clinical Research -
Rochelle L. Maney,
VP, Quality -
Franz Peter Barthold,
VP, Research & Development -
Marshall S. Stanton,
SVP, Clinical & MD Affair -
Anthony B. Semedo,
Director